Connect Biopharma Shifts Strategy, Terminating ADR Program for Nasdaq Direct Listing Connect Biopharma, a clinical-stage biopharmaceutical company focused on...

Urteste S.A. has achieved technological readiness for its Panuri test, a urine-based diagnostic for pancreatic cancer, and plans to...

Disc Medicine’s recent pre-NDA meeting with the FDA regarding bitopertin for erythropoietic protoporphyria (EPP) has yielded positive feedback, paving...

Amneal Pharmaceuticals projects robust second-quarter 2025 results, with net revenue anticipated between $720 million and $730 million, representing a...

Biogen has doubled down on its commitment to North Carolina’s Research Triangle Park (RTP), announcing a $2 billion investment...

Iteos Therapeutics, a clinical-stage biotech company, is being acquired by Concentra Biosciences for $10.047 per share in cash, plus...

Monte Rosa Therapeutics has initiated a Phase 1 trial for MRT-8102, a novel molecular glue degrader (MGD) targeting NEK7...

George Medicines has licensed Widaplik (telmisartan, amlodipine, and indapamide) to Azurity Pharmaceuticals for exclusive commercialization in the US. This...

NewGenIVF Group Limited is taking a calculated leap beyond its core fertility services business through a strategic land development...

Tonix Pharmaceuticals has launched the “Move Fibro Forward” campaign, an initiative designed to raise awareness and support for individuals...